Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer. Zahavi T, Salmon-Divon M, Salgado R, Elkin M, et al. NPJ Breast Cancer 2021;7:67.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zahavi T, Salmon-Divon M, Salgado R, Elkin M, et al. Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer. NPJ Breast Cancer 2021;7:67.
PMID: 34050190